Intracellular signal transduction pathway proteins as targets for cancer therapy

Alex Adjei, Manuel Hidalgo

Research output: Contribution to journalReview article

146 Citations (Scopus)

Abstract

Circulating cytokines, hormones, and growth factors control all aspects of cell proliferation, differentiation, angiogenesis, apoptosis, and senescence. These chemical signals are propagated from the cell surface to intracellular processes via sequential kinase signaling, arranged in modules that exhibit redundancy and cross talk. This signal transduction system comprising growth factors, transmembrane receptor proteins, and cytoplasmic secondary messengers is often exploited to optimize tumor growth and metastasis in malignancies. Thus, it represents an attractive target for cancer therapy. This review will summarize current knowledge of selected intracellular signaling networks and their role in cancer therapy. The focus will be on pathways for which inhibitory agents are currently undergoing clinical testing. Original data for inclusion in this review were identified through a MEDLINE search of the literature. All papers from 1966 through March 2005 were identified by the following search terms: "signal transduction," "intracellular signaling," "kinases," "proliferation," "growth factors," and "cancer therapy." All original research and review papers related to the role of intracellular signaling in oncogenesis and therapeutic interventions relating to abnormal cell signaling were identified. This search was supplemented by a manual search of the Proceedings of the Annual Meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and the American Association for Cancer Research (AARC) - European Organisation for Research and Treatment of Cancer (EORTC) - National Cancer Institute (NCI) Symposium on New Anticancer Drugs.

Original languageEnglish (US)
Pages (from-to)5386-5403
Number of pages18
JournalJournal of Clinical Oncology
Volume23
Issue number23
DOIs
StatePublished - Dec 1 2005
Externally publishedYes

Fingerprint

Signal Transduction
Neoplasms
Proteins
Intercellular Signaling Peptides and Proteins
Phosphotransferases
Therapeutics
Growth Factor Receptors
National Cancer Institute (U.S.)
MEDLINE
Cell Differentiation
Carcinogenesis
Cell Proliferation
Hormones
Apoptosis
Cytokines
Neoplasm Metastasis
Growth
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Intracellular signal transduction pathway proteins as targets for cancer therapy. / Adjei, Alex; Hidalgo, Manuel.

In: Journal of Clinical Oncology, Vol. 23, No. 23, 01.12.2005, p. 5386-5403.

Research output: Contribution to journalReview article

@article{505524594d814a88b1f9f83bf2b19adf,
title = "Intracellular signal transduction pathway proteins as targets for cancer therapy",
abstract = "Circulating cytokines, hormones, and growth factors control all aspects of cell proliferation, differentiation, angiogenesis, apoptosis, and senescence. These chemical signals are propagated from the cell surface to intracellular processes via sequential kinase signaling, arranged in modules that exhibit redundancy and cross talk. This signal transduction system comprising growth factors, transmembrane receptor proteins, and cytoplasmic secondary messengers is often exploited to optimize tumor growth and metastasis in malignancies. Thus, it represents an attractive target for cancer therapy. This review will summarize current knowledge of selected intracellular signaling networks and their role in cancer therapy. The focus will be on pathways for which inhibitory agents are currently undergoing clinical testing. Original data for inclusion in this review were identified through a MEDLINE search of the literature. All papers from 1966 through March 2005 were identified by the following search terms: {"}signal transduction,{"} {"}intracellular signaling,{"} {"}kinases,{"} {"}proliferation,{"} {"}growth factors,{"} and {"}cancer therapy.{"} All original research and review papers related to the role of intracellular signaling in oncogenesis and therapeutic interventions relating to abnormal cell signaling were identified. This search was supplemented by a manual search of the Proceedings of the Annual Meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and the American Association for Cancer Research (AARC) - European Organisation for Research and Treatment of Cancer (EORTC) - National Cancer Institute (NCI) Symposium on New Anticancer Drugs.",
author = "Alex Adjei and Manuel Hidalgo",
year = "2005",
month = "12",
day = "1",
doi = "10.1200/JCO.2005.23.648",
language = "English (US)",
volume = "23",
pages = "5386--5403",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "23",

}

TY - JOUR

T1 - Intracellular signal transduction pathway proteins as targets for cancer therapy

AU - Adjei, Alex

AU - Hidalgo, Manuel

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Circulating cytokines, hormones, and growth factors control all aspects of cell proliferation, differentiation, angiogenesis, apoptosis, and senescence. These chemical signals are propagated from the cell surface to intracellular processes via sequential kinase signaling, arranged in modules that exhibit redundancy and cross talk. This signal transduction system comprising growth factors, transmembrane receptor proteins, and cytoplasmic secondary messengers is often exploited to optimize tumor growth and metastasis in malignancies. Thus, it represents an attractive target for cancer therapy. This review will summarize current knowledge of selected intracellular signaling networks and their role in cancer therapy. The focus will be on pathways for which inhibitory agents are currently undergoing clinical testing. Original data for inclusion in this review were identified through a MEDLINE search of the literature. All papers from 1966 through March 2005 were identified by the following search terms: "signal transduction," "intracellular signaling," "kinases," "proliferation," "growth factors," and "cancer therapy." All original research and review papers related to the role of intracellular signaling in oncogenesis and therapeutic interventions relating to abnormal cell signaling were identified. This search was supplemented by a manual search of the Proceedings of the Annual Meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and the American Association for Cancer Research (AARC) - European Organisation for Research and Treatment of Cancer (EORTC) - National Cancer Institute (NCI) Symposium on New Anticancer Drugs.

AB - Circulating cytokines, hormones, and growth factors control all aspects of cell proliferation, differentiation, angiogenesis, apoptosis, and senescence. These chemical signals are propagated from the cell surface to intracellular processes via sequential kinase signaling, arranged in modules that exhibit redundancy and cross talk. This signal transduction system comprising growth factors, transmembrane receptor proteins, and cytoplasmic secondary messengers is often exploited to optimize tumor growth and metastasis in malignancies. Thus, it represents an attractive target for cancer therapy. This review will summarize current knowledge of selected intracellular signaling networks and their role in cancer therapy. The focus will be on pathways for which inhibitory agents are currently undergoing clinical testing. Original data for inclusion in this review were identified through a MEDLINE search of the literature. All papers from 1966 through March 2005 were identified by the following search terms: "signal transduction," "intracellular signaling," "kinases," "proliferation," "growth factors," and "cancer therapy." All original research and review papers related to the role of intracellular signaling in oncogenesis and therapeutic interventions relating to abnormal cell signaling were identified. This search was supplemented by a manual search of the Proceedings of the Annual Meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and the American Association for Cancer Research (AARC) - European Organisation for Research and Treatment of Cancer (EORTC) - National Cancer Institute (NCI) Symposium on New Anticancer Drugs.

UR - http://www.scopus.com/inward/record.url?scp=23944515326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944515326&partnerID=8YFLogxK

U2 - 10.1200/JCO.2005.23.648

DO - 10.1200/JCO.2005.23.648

M3 - Review article

VL - 23

SP - 5386

EP - 5403

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 23

ER -